Wednesday, July 8, 2026

pharma · Pain · Hyponatremia · CPIX

Cumberland Pharmaceuticals

Cumberland Pharmaceuticals clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

1600 W End Ave, #1300, Nashville, Tennessee 37203, US HQ
1999 Founded
128 Employees
Public company Type
CPIX · NYSE Ticker
Company details
Status
Public
HQ
1600 W End Ave, #1300, Nashville, Tennessee 37203, US
Founded
1999
Employees
128
Programs
53
Drugs
26
Patents
34
Intelligence · Clinical Programs

Cumberland Pharmaceuticals projects

13 ClinicalTrials.gov programs sponsored by Cumberland Pharmaceuticals.

Cumberland Pharmaceuticals has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free)

    CUMBERLAND PHARMACEUTICALS INC

    Acetaminophen Overdose

    phase 3 small molecule terminated

    1 trial
  2. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Burns

    phase 3 small molecule completed

    1 trial
  3. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    phase 3 small molecule completed

    1 trial
  4. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    phase 3 small molecule completed

    1 trial
  5. Conivaptan hydrochloride

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    phase 3 small molecule terminated

    1 trial
  6. Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    phase 3 small molecule completed

    2 trials
  7. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Postoperative Pain

    phase 3 small molecule active

    1 trial
  8. Intravenous ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Tonsillectomy

    phase 3 small molecule completed

    1 trial
  9. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Bacteremia

    phase 3 small molecule terminated

    1 trial
  10. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Bacterial Pneumonia

    phase 3 small molecule completed

    2 trials
  11. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Staphylococcal Skin Infection

    phase 3 small molecule completed

    2 trials
  12. YM087

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    phase 3 small molecule completed

    1 trial
  13. YM087 oral

    CUMBERLAND PHARMACEUTICALS INC

    Hyponatremia

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Cumberland Pharmaceuticals have?

13 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.